364 related articles for article (PubMed ID: 25899717)
41. Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities.
Uchida Y; Irie K; Fukuhara D; Kataoka K; Hattori T; Ono M; Ekuni D; Kubota S; Morita M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29937485
[TBL] [Abstract][Full Text] [Related]
42. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
[TBL] [Abstract][Full Text] [Related]
44. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Onodera S; Sasaki S; Ohshima S; Amizuka N; Li M; Udagawa N; Irie K; Nishihira J; Koyama Y; Shiraishi A; Tohyama H; Yasuda K
J Bone Miner Res; 2006 Jun; 21(6):876-85. PubMed ID: 16753018
[TBL] [Abstract][Full Text] [Related]
45. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
Gilbert LC; Chen H; Lu X; Nanes MS
Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
47. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.
Triliana R; Lam NN; Sawyer RK; Atkins GJ; Morris HA; Anderson PH
J Steroid Biochem Mol Biol; 2016 Nov; 164():331-336. PubMed ID: 26343450
[TBL] [Abstract][Full Text] [Related]
48. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
49. Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair.
Georgy SR; Pagel CN; Ghasem-Zadeh A; Zebaze RM; Pike RN; Sims NA; Mackie EJ
Bone; 2012 Mar; 50(3):704-12. PubMed ID: 22173052
[TBL] [Abstract][Full Text] [Related]
50. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
51. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
52. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.
Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M
Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537
[TBL] [Abstract][Full Text] [Related]
53. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
[TBL] [Abstract][Full Text] [Related]
55. MAGED1 is a negative regulator of bone remodeling in mice.
Liu M; Xu L; Ma X; Xu J; Wang J; Xian M; Zhou X; Wang M; Wang F; Qin A; Pan Q; Wen C
Am J Pathol; 2015 Oct; 185(10):2653-67. PubMed ID: 26272363
[TBL] [Abstract][Full Text] [Related]
56. Chondroitin Sulfate-E Binds to Both Osteoactivin and Integrin αVβ3 and Inhibits Osteoclast Differentiation.
Miyazaki T; Miyauchi S; Anada T; Tawada A; Suzuki O
J Cell Biochem; 2015 Oct; 116(10):2247-57. PubMed ID: 25820496
[TBL] [Abstract][Full Text] [Related]
57. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.
Costa D; Lazzarini E; Canciani B; Giuliani A; Spanò R; Marozzi K; Manescu A; Cancedda R; Tavella S
J Cell Physiol; 2013 Nov; 228(11):2210-21. PubMed ID: 23606520
[TBL] [Abstract][Full Text] [Related]
58. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
59. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
60. The extracellular fragment of GPNMB (Glycoprotein nonmelanosoma protein B, osteoactivin) improves memory and increases hippocampal GluA1 levels in mice.
Murata K; Yoshino Y; Tsuruma K; Moriguchi S; Oyagi A; Tanaka H; Ishisaka M; Shimazawa M; Fukunaga K; Hara H
J Neurochem; 2015 Mar; 132(5):583-94. PubMed ID: 25545823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
